Point72 Middle East FZE’s Atara Biotherapeutics ATRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,421
Closed -$18.2K 94
2023
Q4
$18.2K Buy
+1,421
New +$18.2K ﹤0.01% 818
2023
Q3
Sell
-1,014
Closed -$40.8K 912
2023
Q2
$40.8K Buy
+1,014
New +$40.8K ﹤0.01% 789
2023
Q1
Sell
-1,389
Closed -$114K 1083
2022
Q4
$114K Buy
+1,389
New +$114K 0.01% 715